{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T12:44:31Z","timestamp":1791377071040,"version":"4.3.2"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T00:00:00Z","timestamp":1749600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Tabriz University of Medical Sciences, Iran, Islamic Republic Of","award":["66176"],"award-info":[{"award-number":["66176"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AMB Expr"],"DOI":"10.1186\/s13568-025-01900-x","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T05:02:41Z","timestamp":1749618161000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Immunomodulatory potential of Toxoplasma gondii lysate in C57BL\/6 mouse model of autoimmune encephalomyelitis"],"prefix":"10.1186","volume":"15","author":[{"given":"Maryam","family":"Hajizadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedmousa","family":"Motavallihaghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Badakhsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tohid","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdol Sattar","family":"Pagheh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kareem","family":"Hatam-Nahavandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Ahmadpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,11]]},"reference":[{"issue":"4","key":"1900_CR1","doi-asserted-by":"publisher","first-page":"e12419","DOI":"10.1111\/pim.12419","volume":"39","author":"E Ahmadpour","year":"2017","unstructured":"Ahmadpour E, Sarvi S, Hashemi Soteh M, Sharif M, Rahimi MT, Valadan R, Tehrani M, Khalilian A, Montazeri M, Daryani AJPI (2017) Evaluation of the immune response in BALB\/c mice induced by a novel DNA vaccine expressing GRA 14 against Toxoplasma gondii. Parasite Immunol 39(4):e12419","journal-title":"Parasite Immunol"},{"issue":"12","key":"1900_CR2","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1111\/ene.15055","volume":"28","author":"CE Cicero","year":"2021","unstructured":"Cicero CE, Allibrio FE, Giuliano L, Luna J, Preux PM, Nicoletti A (2021) Toxoplasma gondii and multiple sclerosis: a systematic review and meta-analysis. Eur J Neurol 28(12):4251\u20134257","journal-title":"Eur J Neurol"},{"issue":"1\u20132","key":"1900_CR3","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jneuroim.2011.01.002","volume":"233","author":"J Correale","year":"2011","unstructured":"Correale J, Farez MF (2011) The impact of parasite infections on the course of multiple sclerosis. J Neuroimmunol 233(1\u20132):6\u201311","journal-title":"J Neuroimmunol"},{"key":"1900_CR4","doi-asserted-by":"crossref","unstructured":"Das Sarma J (2010) A mechanism of virus-induced demyelination. Interdiscip Perspect Infect Dis","DOI":"10.1155\/2010\/109239"},{"key":"1900_CR5","doi-asserted-by":"publisher","first-page":"107756","DOI":"10.1016\/j.intimp.2021.107756","volume":"96","author":"M Hajizadeh","year":"2021","unstructured":"Hajizadeh M, Saboor-Yaraghi AA, Meamar AR, Khoshmirsafa M, Razmjou E, Sadeghipour A, Bagheri Y, Sadeghi F, Jalallou N, Kazemi MH (2021) The fatty acid-binding protein (FABP) decreases the clinical signs and modulates immune responses in a mouse model of experimental autoimmune encephalomyelitis (EAE). Int Immunopharmacol 96:107756","journal-title":"Int Immunopharmacol"},{"key":"1900_CR6","doi-asserted-by":"crossref","unstructured":"Hajizadeh M, Jabbari A, Spotin A, Hejazian SS, Mikaeili Galeh T, Hassannia H, Sahlolbei M, Pagheh AS, Ahmadpour JVS (2024) Modulatory effects of hydatid cyst fluid on a mouse model of experimental autoimmune encephalomyelitis. 11(1),34","DOI":"10.3390\/vetsci11010034"},{"issue":"8","key":"1900_CR7","doi-asserted-by":"publisher","first-page":"e37297","DOI":"10.1097\/MD.0000000000037297","volume":"103","author":"M Haki","year":"2024","unstructured":"Haki M, Al-Biati HA, Al-Tameemi ZS, Ali IS, Al-Hussaniy HA (2024) Review of multiple sclerosis: epidemiology, etiology, pathophysiology, and treatment. Medicine 103(8):e37297","journal-title":"Medicine"},{"issue":"2","key":"1900_CR8","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1159\/000180267","volume":"16","author":"S Henriquez","year":"2009","unstructured":"Henriquez S, Brett R, Alexander J, Pratt J, Roberts C (2009) Neuropsychiatric disease and Toxoplasma gondii infection. NeuroImmunoModulation 16(2):122\u2013133","journal-title":"NeuroImmunoModulation"},{"issue":"7","key":"1900_CR9","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1093\/intimm\/8.7.1001","volume":"8","author":"A Inoue","year":"1996","unstructured":"Inoue A, Koh C-S, Yahikozawa H, Yanagisawa N, Yagita H, Ishihara Y, Kim BS (1996) The level of tumor necrosis factor-\u03b1 producing cells in the spinal cord correlates with the degree of Theiler\u2019s murine encephalomyelitis virus-induced demyelinating disease. Int Immunol 8(7):1001\u20131008","journal-title":"Int Immunol"},{"issue":"5","key":"1900_CR10","doi-asserted-by":"publisher","first-page":"365","DOI":"10.3109\/08830185.2014.941239","volume":"33","author":"MC Internati","year":"2014","unstructured":"Internati MC, Mirandola L, Bot A (2014) International reviews of immunology. Int Rev Immunol 33(5):365\u2013366","journal-title":"Int Rev Immunol"},{"issue":"5","key":"1900_CR11","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1093\/schbul\/sbl058","volume":"33","author":"SR Jones","year":"2007","unstructured":"Jones SR, Fernyhough C (2007) A new look at the neural diathesis\u2013stress model of schizophrenia: the primacy of social-evaluative and uncontrollable situations. Schizophr Bull 33(5):1171\u20131177","journal-title":"Schizophr Bull"},{"key":"1900_CR12","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3389\/fnins.2013.00204","volume":"7","author":"D Kamimura","year":"2013","unstructured":"Kamimura D, Yamada M, Harada M, Sabharwal L, Jie M, Bando H, Ogura H, Atsumi T, Arima Y, Murakami M (2013) The gateway theory: bridging neural and immune interactions in the CNS. Front Neurosci 7:204","journal-title":"Front Neurosci"},{"key":"1900_CR13","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.msard.2017.04.004","volume":"15","author":"A Koskderelioglu","year":"2017","unstructured":"Koskderelioglu A, Afsar I, Pektas B, Gedizlioglu M (2017) Is Toxoplasma gondii infection protective against multiple sclerosis risk? Mult Scler Relat Disord 15:7\u201310","journal-title":"Mult Scler Relat Disord"},{"key":"1900_CR14","doi-asserted-by":"crossref","unstructured":"Kruger NJ (2009) The Bradford method for protein quantitation. 17\u201324","DOI":"10.1007\/978-1-59745-198-7_4"},{"key":"1900_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1590\/S0074-02762004000900006","volume":"99","author":"AC La Flamme","year":"2004","unstructured":"La Flamme AC, Canagasabey K, Harvie M, B\u00e4ckstr\u00f6m BT (2004) Schistosomiasis protects against multiple sclerosis. Mem Inst Oswaldo Cruz 99:33\u201336","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"3","key":"1900_CR16","doi-asserted-by":"publisher","first-page":"a028936","DOI":"10.1101\/cshperspect.a028936","volume":"8","author":"H Lassmann","year":"2018","unstructured":"Lassmann H (2018) Multiple sclerosis pathology. Cold Spring Harb Perspect Med 8(3):a028936","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"4","key":"1900_CR17","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3109\/08830185.2013.823422","volume":"33","author":"JE Libbey","year":"2014","unstructured":"Libbey JE, Cusick MF, Fujinami RS (2014) Role of pathogens in multiple sclerosis. Int Rev Immunol 33(4):266\u2013283","journal-title":"Int Rev Immunol"},{"issue":"8","key":"1900_CR18","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1038\/s41582-019-0184-2","volume":"15","author":"AF Lloyd","year":"2019","unstructured":"Lloyd AF, Miron VE (2019) The pro-remyelination properties of microglia in the central nervous system. Nat Rev Neurol 15(8):447\u2013458","journal-title":"Nat Rev Neurol"},{"key":"1900_CR19","doi-asserted-by":"crossref","unstructured":"Mamizadeh M, Maleki F, Mohammadi MR, Shamsi L, Asghari A, Pouryousef A (2025) Seroprevalence and risk factors for Toxoplasma gondii infection in solid organ transplant patients: a global systematic review and meta-analysis. Parasite Epidemiol Control e00421","DOI":"10.1016\/j.parepi.2025.e00421"},{"issue":"6\u20137","key":"1900_CR20","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.neuropharm.2009.02.007","volume":"56","author":"A Mirshafiey","year":"2009","unstructured":"Mirshafiey A, Mohsenzadegan M (2009) TGF-\u03b2 as a promising option in the treatment of multiple sclerosis. Neuropharmacology 56(6\u20137):929\u2013936","journal-title":"Neuropharmacology"},{"issue":"1","key":"1900_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12964-025-02168-1","volume":"23","author":"K Moradi","year":"2025","unstructured":"Moradi K, Moghaddami R, Ghaffari-Nasab A, Khordadmehr M, Pagheh AS, Mosajakhah H, Rezaei S, Gharepapagh E, Ahmadi M, Montazeri M (2025) Toxoplasma gondii modulates immune responses and mitigates type 1 diabetes progression in a streptozotocin-induced rat model. Cell Commun Signal 23(1):1\u201312","journal-title":"Cell Commun Signal"},{"issue":"12","key":"1900_CR22","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1038\/nri2448","volume":"8","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8(12):958\u2013969","journal-title":"Nat Rev Immunol"},{"key":"1900_CR23","doi-asserted-by":"publisher","first-page":"110379","DOI":"10.1016\/j.intimp.2023.110379","volume":"120","author":"S Motavallihaghi","year":"2023","unstructured":"Motavallihaghi S, Ghaemipanaeian M, Asl SS, Foroughi-Parvar F, Maghsood AH (2023) Toxoplasma gondii attenuates the Ethidium bromide induced demyelination lesions in multiple sclerosis model rats. Int Immunopharmacol 120:110379","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"1900_CR24","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.2174\/0929867323666160311114110","volume":"23","author":"AN Pe\u00f3n","year":"2016","unstructured":"Pe\u00f3n AN, Terrazas LI (2016) Immune-regulatory mechanisms of classical and experimental multiple sclerosis drugs: a special focus on helminth-derived treatments. Curr Med Chem 23(11):1152\u20131170","journal-title":"Curr Med Chem"},{"issue":"4","key":"1900_CR25","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1212\/01.CON.0000433291.23091.65","volume":"19","author":"BFG Popescu","year":"2013","unstructured":"Popescu BFG, Pirko I, Lucchinetti CF (2013) Pathology of multiple sclerosis: where do we stand? Contin Lifelong Learn Neurol 19(4):901","journal-title":"Contin Lifelong Learn Neurol"},{"issue":"10","key":"1900_CR26","doi-asserted-by":"publisher","first-page":"3139","DOI":"10.1074\/mcp.M116.059774","volume":"15","author":"A Ravid\u00e0","year":"2016","unstructured":"Ravid\u00e0 A, Cwiklinski K, Aldridge AM, Clarke P, Thompson R, Gerlach JQ, Kilcoyne M, Hokke CH, Dalton JP, O\u2019Neill SM (2016) Fasciola hepatica surface tegument: glycoproteins at the interface of parasite and host. Mol Cell Proteom 15(10):3139\u20133153","journal-title":"Mol Cell Proteom"},{"issue":"4","key":"1900_CR27","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1084\/jem.172.4.1193","volume":"172","author":"NH Ruddle","year":"1990","unstructured":"Ruddle NH, Bergman CM, McGrath KM, Lingenheld EG, Grunnet ML, Padula S, Clark RB (1990) An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 172(4):1193\u20131200","journal-title":"J Exp Med"},{"key":"1900_CR28","first-page":"1368","volume":"4","author":"M Saadatnia","year":"2012","unstructured":"Saadatnia M, Homayouni V, Nikoogoftar M, Maghzi A, Etemadifar M, Chaitanya V, McGee J, Minagar A, Alexander J (2012) Interferon-beta-1b protects against multiple sclerosis-induced endothelial cells apoptosis. Front Biosci (Elite Ed) 4:1368\u20131374","journal-title":"Front Biosci (Elite Ed)"},{"key":"1900_CR29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jneuroim.2018.06.011","volume":"322","author":"R Saberi","year":"2018","unstructured":"Saberi R, Sharif M, Sarvi S, Aghayan SA, Hosseini SA, Anvari D, Chegeni TN, Hosseininejad Z, Daryani A (2018) Is Toxoplasma gondii playing a positive role in multiple sclerosis risk? A systematic review and meta-analysis. J Neuroimmunol 322:57\u201362","journal-title":"J Neuroimmunol"},{"key":"1900_CR30","doi-asserted-by":"crossref","unstructured":"Safarpour H, Cevik M, Zarean M, Barac A, Hatam-Nahavandi K, Rahimi MT, Baghi HB, Koshki TJ, Pagheh AS, Shahrivar FJA (2020) Global status of Toxoplasma gondii infection and associated risk factors in people living with HIV. 34(3):469\u2013474","DOI":"10.1097\/QAD.0000000000002424"},{"issue":"24","key":"1900_CR31","doi-asserted-by":"publisher","first-page":"17273","DOI":"10.3390\/ijms242417273","volume":"24","author":"K Sounbuli","year":"2023","unstructured":"Sounbuli K, Alekseeva LA, Markov OV, Mironova NL (2023) A comparative study of different protocols for isolation of murine neutrophils from bone marrow and spleen. Int J Mol Sci 24(24):17273","journal-title":"Int J Mol Sci"},{"key":"1900_CR32","doi-asserted-by":"crossref","unstructured":"Stiemsma LT, Reynolds LA, Turvey SE, Finlay BB (2015) The hygiene hypothesis: current perspectives and future therapies. ImmunoTargets Ther 143\u2013157.","DOI":"10.2147\/ITT.S61528"},{"issue":"9","key":"1900_CR33","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1084\/jem.20042572","volume":"202","author":"MS Wilson","year":"2005","unstructured":"Wilson MS, Taylor MD, Balic A, Finney CA, Lamb JR, Maizels RM (2005) Suppression of allergic airway inflammation by helminth-induced regulatory T cells. J Exp Med 202(9):1199\u20131212","journal-title":"J Exp Med"},{"key":"1900_CR34","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20240354","author":"C Xu","year":"2024","unstructured":"Xu C, Obers A, Qin M, Brandli A, Wong J, Huang X, Clatch A, Fayed A, Starkey G, D\u2019Costa R (2024) Selective regulation of IFN-\u03b3 and IL-4 co-producing unconventional T cells by purinergic signaling. J Exp Med. https:\/\/doi.org\/10.1084\/jem.20240354","journal-title":"J Exp Med"},{"key":"1900_CR35","doi-asserted-by":"publisher","first-page":"e18072","DOI":"10.7717\/peerj.18072","volume":"12","author":"Y Zeng","year":"2024","unstructured":"Zeng Y, Tang X, Chen J, Kang X, Bai D (2024) Optimizing total RNA extraction method for human and mice samples. PeerJ 12:e18072","journal-title":"PeerJ"}],"container-title":["AMB Express"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-025-01900-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13568-025-01900-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13568-025-01900-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T05:02:45Z","timestamp":1749618165000},"score":1,"resource":{"primary":{"URL":"https:\/\/amb-express.springeropen.com\/articles\/10.1186\/s13568-025-01900-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,11]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1900"],"URL":"https:\/\/doi.org\/10.1186\/s13568-025-01900-x","relation":{},"ISSN":["2191-0855"],"issn-type":[{"value":"2191-0855","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,11]]},"assertion":[{"value":"29 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The animal study protocol was approved by the Ethics Committee of Tabriz University of Medical Sciences, Tabriz, Iran (protocol code IR.TBZMED.VCR.REC. 1400.153).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"89"}}